Fundraising Fox
Caldre
1 known investors
Find your way into Caldre
Sign up to find every way you can get introduced to Caldre
- Your email: who you already know at Caldre, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Caldre team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
CALDRE is a Switzerland-based biotech spin-out developing liver-directed GalNAc-siRNA therapeutics, including its claudin-3 targeting candidate ClagalsiR, to restore bile flow and prevent fibrosis. It aims to treat cholestatic and fibrotic liver diseases such as primary sclerosing cholangitis and primary biliary cholangitis and reduce the need for liver transplantation.
Investors · 1
Kickfund✓ confirmed by CaldreBasel · $950K
How we know: Kickfund's portfolio page · the company's own site · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Caldre do?
- CALDRE is a Switzerland-based biotech spin-out developing liver-directed GalNAc-siRNA therapeutics, including its claudin-3 targeting candidate ClagalsiR, to restore bile flow and prevent fibrosis. It aims to treat cholestatic and fibrotic liver diseases such as primary sclerosing cholangitis and primary biliary cholangitis and reduce the need for liver transplantation.
- Who are Caldre's investors?
- Caldre's investors include Kickfund.